Features

The Features section includes articles on topics, events, people, and initiatives of interest to the oncology community.

Mar 04, 2021
Dr. Sherilyn Tuazon is innovating new approaches to autologous stem cell transplant (ASCT) treatment for patients with multiple myeloma.
Mar 04, 2021
“Our careers have honored the lives of our patients, and it’s a part of our legacy we want to continue,” said Dr. Frank Ferris. “We chose Conquer Cancer because of ASCO’s commitment to changing the lives of patients and families through education domestically and internationally.”
Mar 04, 2021
On March 4, a meeting of the Lancet Oncology Commission on Medical and Nuclear Imaging, of which ASCO is a part, took place as part of the European Congress of Radiology (ECR) 2021.
Feb 12, 2021
Much of the progress of the past 5 decades was catalyzed by the National Cancer Act, signed into law by President Richard Nixon in December 1971.
Jan 15, 2021
A new special series includes guidance on factors and decision-making processes for selecting the right platform, how to reduce expenses from manual burdens, and how to allocate resources to successfully enable NGS for clinical cancer care. 
Jan 15, 2021
Conquer Cancer, the ASCO Foundation, has a new funding partner for a program aimed at recruiting and retaining young physician-scientists committed to research in symptom management.
Jan 15, 2021
With support from a Conquer Cancer International Innovation Grant (IIG), Dr. Tonia Onyeka developed Enhancing Palliative Care (EPAC), a mobile application for patients living in resource-limited regions to self-report symptoms and remotely connect with their care teams. 
Jan 14, 2021
Dr. S. Gail Eckhardt acknowledges the importance and impact of mentoring women oncologists in the early years of their career.
Jan 12, 2021
Through 2020, ASCO began to determine how it could allocate the same level of energy and resources towards equity in cancer care as it did towards research, education, and promotion of high-quality care. 
Dec 21, 2020
Researchers found that Black patients with cancer were almost 2 times more likely (relative risk 1.69) and Hispanic patients were more than 5 times more likely (relative risk 5.25) to test positive for COVID-19 compared with white patients

Pages